Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Citi
McKinsey
Fuji
Moodys

Generated: June 19, 2019

DrugPatentWatch Database Preview

Betamethasone valerate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for betamethasone valerate and what is the scope of betamethasone valerate patent protection?

Betamethasone valerate is the generic ingredient in eight branded drugs marketed by Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Mylan Pharms Inc, G And W Labs Inc, Roaco, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Savage Labs, Schering, Actavis Mid Atlantic, Sti Pharma Llc, and Teva Pharms, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone valerate. Eighteen suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for betamethasone valerate
Medical Subject Heading (MeSH) Categories for betamethasone valerate
Synonyms for betamethasone valerate
(11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate
(11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
(2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl p
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate
1,4-Pregnadiene-11beta,17alpha,21-triol-9alpha-fluoro-16beta-methyl-3,20-dione 17-valerate
12772-60-0
149665-14-5
152M445
2152-44-5
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate
9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate
9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate
944728-94-3
9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate
9alpha-Fluoro-16beta-methylprednisolone 17-valerate
9IFA5XM7R2
AB01274710_02
AB01274710-01
AB2000222
AC1L285F
AKOS015994704
AN-14218
Bedermin
beta-Methasone 17-valerate
beta-Val
Beta-Val (TN)
Betaderm
Betamethason-17-valerate
Betamethasone 17-valerate
Betamethasone 17a-valerate
Betamethasone 17alpha-valerate
Betamethasone Valerate (Betamethasone 17-Valerate)
Betamethasone valerate (Betnovate)
Betamethasone valerate (JP17/USP)
Betamethasone valerate [USAN:BAN:JAN]
Betamethasone valerate [USAN:USP:JAN]
Betamethasone-17-valerate
Betatrex (Salt/Mix)
Betaval
Betnesol V
Betnesol-V
Betneval
Betnovate
Betnovate;Celestone;Betaderm;Luxiq
Betnovateat
Betoid
Bettamousse
Bextasol
BRD-K34032314-001-04-1
C27H37FO6
CAS-2152-44-5
Celestan V
Celestan-V
Celestane V
Celestoderm
Celestoderm V
Celestoderm-V
Celeston valerate
CHEBI:31277
CHEMBL1497
Chlorophytum Borivilanum
D01357
Dermosol
Dermovaleas
DSSTox_CID_2673
DSSTox_GSID_22673
DSSTox_RID_76684
DTXSID7022673
Ecoval 70
EINECS 218-439-3
entanoate
Flubenisolonvalerate
Fuciderm
Gentocin (Salt/Mix)
Gentocin (Veterinary)
KS-1198
LS-118456
Luxiq
Luxiq (TN)
MFCD00867446
MolPort-003-933-651
NCGC00255185-01
NCGC00274064-01
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-,(11-beta,16-beta)-
Rinderon V
Rinderon-V (TN)
RL02645
s1690
SCHEMBL7270
SNHRLVCMMWUAJD-SUYDQAKGSA-N
ST075178
Stanoval
Tokuderm
Topagen (Salt/Mix)
Topagen (Veterinary)
Tox21_302288
UNII-9IFA5XM7R2
Valnac
ZINC3882052
Generic filers with tentative approvals for BETAMETHASONE VALERATE
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up0.12%FOAM;TOPICAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering VALISONE betamethasone valerate CREAM;TOPICAL 016322-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018865-001 Aug 31, 1983 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Mid Atlantic VALNAC betamethasone valerate CREAM;TOPICAL 070050-001 Oct 10, 1984 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering VALISONE betamethasone valerate LOTION;TOPICAL 016932-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair BETAMETHASONE VALERATE betamethasone valerate LOTION;TOPICAL 070484-001 May 29, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sti Pharma Llc BETAMETHASONE VALERATE betamethasone valerate LOTION;TOPICAL 070052-001 Jul 31, 1985 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018864-001 Aug 31, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999 ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Colorcon
Fuji
Mallinckrodt
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.